Literature DB >> 14532867

Assisted reproductive technology surveillance--United States, 2000.

Victoria C Wright1, Laura A Schieve, Meredith A Reynolds, Gary Jeng.   

Abstract

PROBLEM/CONDITION: In 1996, CDC initiated data collection regarding assisted reproductive technology (ART) procedures performed in the United States to determine medical center-specific pregnancy success rates, as mandated by the Fertility Clinic Success Rate and Certification Act (FCSRCA) (Public Law 102-493, October 24, 1992). ART includes fertility treatments in which both eggs and sperm are handled in the laboratory (i.e., in vitro fertilization and related procedures). Patients who undergo ART treatments are more likely to deliver multiple-birth infants than women who conceive naturally. Multiple births are associated with increased risk for mothers and infants (e.g., pregnancy complications, premature delivery, low-birthweight infants, and long-term disability among infants). REPORTING PERIOD COVERED: 2000. DESCRIPTION OF SYSTEM: CDC contracts with a professional society, the Society for Assisted Reproductive Technology (SART), to obtain data from fertility medical centers located in the United States. Since 1997, CDC has compiled data related to ART procedures. The Assisted Reproductive Technology Surveillance System was initiated by CDC in collaboration with the American Society for Reproductive Medicine, the Society for Assisted Reproductive Technology, and RESOLVE: The National Infertility Association.
RESULTS: In 2000, a total of 25,228 live-birth deliveries and 35,025 infants resulting from 99,629 ART procedures were reported to CDC from 383 medical centers that performed ART in the United States and U.S. territories. Nationally, 75,516 (76%) of ART treatments were freshly fertilized embryos using the patient's eggs; 13,312 (13%) were thawed embryos using the patient's eggs; 7,919 (8%) were freshly fertilized embryos from donor eggs; and 2,882 (3%) were thawed embryos from donor eggs. The national live-birth delivery per transfer rate was 30.8%. The five states that reported the highest number of ART procedures were California (13,194), New York (11,239), Massachusetts (8,041), Illinois (7,323), and New Jersey (5,506). These five states also reported the highest number of live-birth deliveries and infants born as a result of ART. Overall, 47% of women undergoing ART-transfer procedures using freshly fertilized embryos from their own eggs were aged <35 years; 23% were aged 35-37 years; 19% were aged 38-40 years; 7% were aged 41-42 years; and 4% were aged >42 years. Among ART treatments in which freshly fertilized embryos from the patient's eggs were used, substantial variation in patient age, infertility diagnoses, history of past infertility treatment, and past births was observed. Nationally, live-birth rates were highest for women aged <35 years (38%). The risk for a multiple-birth delivery was highest for women who underwent ART-transfer procedures using freshly fertilized embryos from either donor eggs (40%) or from their own eggs (35%). Among women who underwent ART-transfer procedures using freshly fertilized embryos from their own eggs, further variation by patient age and number of embryos transferred was observed. Of the 35,025 infants born, 44% were twins, and 9% were triplet and higher order multiples, for a total multiple-infant birth rate of 53%. Patient's residing in states with the highest number of live-birth deliveries also reported the highest number of infants born in multiple-birth deliveries.
INTERPRETATION: Whether an ART procedure was successful (defined as resulting in a pregnancy and live-birth delivery) varied according to different patient and treatment factors. Patient factors included the age of the woman undergoing ART, whether she had previously given birth, whether she had previously undergone ART, and the infertility diagnosis of both the female and male partners. Treatment factors included whether eggs were from the patient or a woman serving as an egg donor, whether the embryos were freshly fertilized or previously frozen and thawed, how long the embryos were kept in culture, how many embryos were transferred, and whether various specialized treatment procedures were used in conjunction with ART. ART poses a major risk for multiple births. This risk varied according to the patient's age, the type of ART procedure performed, and the number of embryos transferred. In addition, the increased risk for multiple births has a notable population impact in certain states. PUBLIC HEALTH ACTIONS: As use of ART and ART success rates continue to increase, ART-related multiple births are an increasingly important public health problem nationally and in many states. The proportion of infants born through ART in 2000 that were multiple births (53%) was substantially higher than in the general U.S. population during the same period. Data in this report indicate a need to reduce multiple births associated with ART. Efforts should be made to limit the number of embryos transferred for patients undergoing ART. In addition, continued research and surveillance is key to understanding the effect of ART on maternal and child health.

Entities:  

Mesh:

Year:  2003        PMID: 14532867

Source DB:  PubMed          Journal:  MMWR Surveill Summ        ISSN: 1545-8636


  21 in total

1.  Utilization of infertility treatments: the effects of insurance mandates.

Authors:  Marianne P Bitler; Lucie Schmidt
Journal:  Demography       Date:  2012-02

2.  Epigenetics and assisted reproductive technology: a call for investigation.

Authors:  Emily L Niemitz; Andrew P Feinberg
Journal:  Am J Hum Genet       Date:  2004-02-27       Impact factor: 11.025

3.  Cancer in women after assisted reproductive technology.

Authors:  Barbara Luke; Morton B Brown; Logan G Spector; Stacey A Missmer; Richard E Leach; Melanie Williams; Lori Koch; Yolanda Smith; Judy E Stern; G David Ball; Maria J Schymura
Journal:  Fertil Steril       Date:  2015-08-10       Impact factor: 7.329

4.  Preterm birth in twins after subfertility treatment: population based cohort study.

Authors:  Hans Verstraelen; Sylvie Goetgeluk; Catherine Derom; Stijn Vansteelandt; Robert Derom; Els Goetghebeur; Marleen Temmerman
Journal:  BMJ       Date:  2005-10-25

5.  Early Autism Spectrum Disorders in Children Born to Fertile, Subfertile, and ART-Treated Women.

Authors:  Hafsatou Diop; Howard Cabral; Daksha Gopal; Xiaohui Cui; Judy E Stern; Milton Kotelchuck
Journal:  Matern Child Health J       Date:  2019-11

6.  Application of a validated prediction model for in vitro fertilization: comparison of live birth rates and multiple birth rates with 1 embryo transferred over 2 cycles vs 2 embryos in 1 cycle.

Authors:  Barbara Luke; Morton B Brown; Ethan Wantman; Judy E Stern; Valerie L Baker; Eric Widra; Charles C Coddington; William E Gibbons; Bradley J Van Voorhis; G David Ball
Journal:  Am J Obstet Gynecol       Date:  2015-02-13       Impact factor: 8.661

7.  Acid ceramidase improves the quality of oocytes and embryos and the outcome of in vitro fertilization.

Authors:  Efrat Eliyahu; Nataly Shtraizent; Kurt Martinuzzi; Jason Barritt; Xingxuan He; Hong Wei; Sanjeev Chaubal; Alan B Copperman; Edward H Schuchman
Journal:  FASEB J       Date:  2009-12-09       Impact factor: 5.191

8.  Assisted reproduction technologies impair placental steroid metabolism.

Authors:  Abby C Collier; Shogo J Miyagi; Yasuhiro Yamauchi; Monika A Ward
Journal:  J Steroid Biochem Mol Biol       Date:  2009-05-03       Impact factor: 4.292

9.  In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters.

Authors:  Barbara Luke; Morton B Brown; Michael L Eisenberg; Caitriona Callan; Beverley J Botting; Allan Pacey; Alastair G Sutcliffe; Valerie L Baker
Journal:  Am J Obstet Gynecol       Date:  2019-10-17       Impact factor: 8.661

Review 10.  Approaches to improve the diagnosis and management of infertility.

Authors:  P Devroey; B C J M Fauser; K Diedrich
Journal:  Hum Reprod Update       Date:  2009-04-20       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.